AU2001235617A1 - Immunostimulatory oligonucleotides - Google Patents

Immunostimulatory oligonucleotides

Info

Publication number
AU2001235617A1
AU2001235617A1 AU2001235617A AU3561701A AU2001235617A1 AU 2001235617 A1 AU2001235617 A1 AU 2001235617A1 AU 2001235617 A AU2001235617 A AU 2001235617A AU 3561701 A AU3561701 A AU 3561701A AU 2001235617 A1 AU2001235617 A1 AU 2001235617A1
Authority
AU
Australia
Prior art keywords
immunostimulatory oligonucleotides
immunostimulatory
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235617A
Inventor
Monique Bachy
Regis Sodoyer
Emanuelle Trannoy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Publication of AU2001235617A1 publication Critical patent/AU2001235617A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001235617A 2000-02-18 2001-02-07 Immunostimulatory oligonucleotides Abandoned AU2001235617A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0002056 2000-02-18
FR0002056A FR2805264B1 (en) 2000-02-18 2000-02-18 IMMUNOSTIMULATING OLIGONUCLEOTIDES
PCT/FR2001/000350 WO2001062910A1 (en) 2000-02-18 2001-02-07 Immunostimulatory oligonucleotides

Publications (1)

Publication Number Publication Date
AU2001235617A1 true AU2001235617A1 (en) 2001-09-03

Family

ID=8847155

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235617A Abandoned AU2001235617A1 (en) 2000-02-18 2001-02-07 Immunostimulatory oligonucleotides

Country Status (3)

Country Link
AU (1) AU2001235617A1 (en)
FR (1) FR2805264B1 (en)
WO (1) WO2001062910A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2388049A1 (en) 2002-05-30 2003-11-30 Immunotech S.A. Immunostimulatory oligonucleotides and uses thereof
EA201290876A1 (en) 2010-03-05 2013-03-29 Президент Энд Феллоуз Оф Гарвард Колледж COMPOSITIONS OF INDUCED DENDRITIC CELLS AND THEIR USE

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420171T1 (en) * 1994-07-15 2009-01-15 Univ Iowa Res Found IMMUNOMODULATORY OLIGONUCLEOTIDES
CA2289741A1 (en) * 1997-05-19 1998-11-26 Merck & Co., Inc. Oligonucleotide adjuvant

Also Published As

Publication number Publication date
FR2805264B1 (en) 2002-04-12
WO2001062910A1 (en) 2001-08-30
FR2805264A1 (en) 2001-08-24

Similar Documents

Publication Publication Date Title
HUP0301229A3 (en) Immunostimulatory oligodeoxynucleotides
AU6419701A (en) Electropancreatography
AU2001262847A1 (en) Language-understanding
AU2001292739A1 (en) 1-oxorapamycins
AU2001254546A1 (en) Aminopiperidines
AU2000267458A1 (en) Hypercomputer
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2002211620A1 (en) Autoanastomosis
AU2001258349A1 (en) Bisacylguanidine
AU2001296577A1 (en) Chlorophyllases
AU2001279754A1 (en) Indoloquinazolinones
AU2002211128A1 (en) Step-bike
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001244687A1 (en) Micro-array
AU2001258924A1 (en) Microsatellite-aflp
AU2001293852A1 (en) Sulfonylguanidine
AU2002245107A1 (en) Improved biochip
AU2002226346A1 (en) 2-aryl-5-trifluoromethylpyridines
AU2001240791A1 (en) Sequence
AU2001235616A1 (en) Immunostimulatory oligonucleotides
AU2001240103A1 (en) Reproduction-specific genes
AU2001281921A1 (en) Bdellosomes
AU2001291876A1 (en) Triazolo-epothilones